InGel Website
4 known investors
Find your way into InGel Website
268 people in our graph share verified history with the InGel Website team — schools, employers, funds. One of them is your warm intro.
Karthik Ardhanareeswaranunlockedknows Deepti Singh · together at Yale School of Medicine (overlapped)
×6knows the team · via Harvard Medical School
×2knows the team · via Yale School of Medicine
×2knows the team · via Mass. Eye and Ear
knows the team · via University of Madras
InGel Therapeutics develops engineered cell therapies for complex retinal degenerative diseases, combining retinal precursor cells with a biomimetic hyaluronic acid and gelatin hydrogel delivery matrix that mimics the human vitreous. The company also runs Regenesis, a target discovery platform using single-cell proteomics to identify neuroprotective pathways in the eye.
Founders & leadership
PJ
Patrick JianginCEO & Co-founder
PC
Pierre Colombe DromelinChief Technology Officer & Co-founder
DS
Deepti SinghinChief Scientific Officer & Co-founderDeepti Singh holds a Ph.D. in biomaterials-based tissue regeneration and trained at Yale and Harvard University. She is Co-founder and Chief Scientific Officer of InGel Therapeutics, which develops engineered cell therapies for retinal degenerative diseases using biomimetic hydrogel delivery systems.
Investors · 4
Frequently asked questions
- What does InGel Website do?
- InGel Therapeutics develops engineered cell therapies for complex retinal degenerative diseases, combining retinal precursor cells with a biomimetic hyaluronic acid and gelatin hydrogel delivery matrix that mimics the human vitreous. The company also runs Regenesis, a target discovery platform using single-cell proteomics to identify neuroprotective pathways in the eye.
- Who founded InGel Website?
- InGel Website was founded by Patrick Jiang, Pierre Colombe Dromel, Deepti Singh.
- Who are InGel Website's investors?
- InGel Website's investors include MassVentures, Service Provider Capital, The Venture Collective, ZAKA VC.